Bessemer Group
ANAB icon

Bessemer Group’s AnaptysBio ANAB Stock Holding History

Bessemer Group’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96K Hold
1,428
– – ﹤0.01% 1533
2026
Q1 		$79K Sell
1,428
-33
-2% -$1.78K ﹤0.01% 1551
2025
Q4 		$71K Buy
1,461
+33
+2% +$1.29K ﹤0.01% 1543
2025
Q3 		$44K Buy
1,428
+1,292
+950% +$29.7K ﹤0.01% 1465
2025
Q2 		$3K Buy
136
+110
+423% +$2.3K ﹤0.01% 2108
2025
Q1 		$0 Buy
+26
New +$434 ﹤0.01% 2428
2024
Q4 		– Sell
-50
Closed -$2K – 2447
2024
Q3 		$2K Buy
+50
New +$1.71K ﹤0.01% 2160

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Bessemer Group's ANAB Position: Q2 2026 in Review

Bessemer Group held its AnaptysBio (ANAB) position steady in Q2 2026 at 1,428 shares worth $96K. The position accounts for ﹤0.01% of the portfolio, ranked #1533.

Bessemer Group first reported a position in ANAB in Q3 2024 and has held it in 7 quarters since. 214 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Bessemer Group held 1,428 shares of AnaptysBio worth $96K as of Q2 2026.
  • Bessemer Group left its AnaptysBio share count unchanged in Q2 2026.
  • AnaptysBio made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1533 holding.
  • Bessemer Group first reported a position in AnaptysBio in Q3 2024 and has held it in 7 quarters since.
  • 214 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.